CARDIFF ONCOLOGY, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
CARDIFF ONCOLOGY, INC. (CRDF) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$6.80 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2019-08-08
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-06-30 was -$3.44M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-03-31 was -$3.36M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-12-31 was -$3.61M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-09-30 was -$3.48M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2018 was -$13.20M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$23.28M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$31.04M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$22.12M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 152 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 155 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 158 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 161 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 164 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 167 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 170 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 173 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$6.80M 10-Q · filed 2019-08-08 | -$10.42M derived: sum of 3 quarters · filed 2019-08-08 | -$13.90M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2019-03-31 | -$3.36M 10-Q · filed 2019-05-07 | -$6.97M derived: sum of 2 quarters · filed 2019-05-07 | -$10.45M derived: sum of 3 quarters · filed 2019-05-07 | -$13.70M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-12-31 | -$3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$7.09M derived: sum of 2 quarters · filed 2019-03-06 | -$10.34M derived: sum of 3 quarters · filed 2019-08-08 | -$13.20M 10-K · filed 2019-03-06 | |||||||||
| 2018-09-30 | -$3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$6.73M derived: sum of 2 quarters · filed 2019-08-08 | -$9.59M 10-Q · filed 2018-11-07 | -$12.92M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-06-30 | -$3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$6.11M 10-Q · filed 2019-08-08 | -$9.44M derived: sum of 3 quarters · filed 2019-08-08 | -$16.03M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-03-31 | -$2.86M 10-Q · filed 2019-05-07 | -$6.19M derived: sum of 2 quarters · filed 2019-05-07 | -$12.78M derived: sum of 3 quarters · filed 2019-05-07 | -$17.38M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2017-12-31 | -$3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$9.93M derived: sum of 2 quarters · filed 2019-03-06 | -$14.52M derived: sum of 3 quarters · filed 2019-03-06 | -$23.28M 10-K · filed 2019-03-06 | |||||||||
| 2017-09-30 | -$6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$11.19M derived: sum of 2 quarters · filed 2018-11-07 | -$19.95M 10-Q · filed 2018-11-07 | -$28.95M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||
| 2017-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$13.36M 10-Q · filed 2018-08-03 | -$22.36M derived: sum of 3 quarters · filed 2018-08-03 | -$29.40M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | -$8.76M 10-Q · filed 2018-05-08 | -$17.76M derived: sum of 2 quarters · filed 2018-05-08 | -$24.80M derived: sum of 3 quarters · filed 2018-05-08 | -$32.88M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||
| 2016-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$16.05M derived: sum of 2 quarters · filed 2018-02-26 | -$24.12M derived: sum of 3 quarters · filed 2018-02-26 | -$31.04M 10-K · filed 2018-02-26 | |||||||||
| 2016-09-30 | -$7.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$15.12M derived: sum of 2 quarters · filed 2017-11-09 | -$22.03M 10-Q · filed 2017-11-09 | -$28.84M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||
| 2016-06-30 | -$8.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$14.99M 10-Q · filed 2017-08-09 | -$21.80M derived: sum of 3 quarters · filed 2017-08-09 | -$26.94M derived: sum of 4 quarters · filed 2017-08-09 | |||||||||
| 2016-03-31 | -$6.92M 10-Q · filed 2017-05-10 | -$13.72M derived: sum of 2 quarters · filed 2017-05-10 | -$18.86M derived: sum of 3 quarters · filed 2017-05-10 | -$24.30M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||
| 2015-12-31 | -$6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$11.94M derived: sum of 2 quarters · filed 2017-03-15 | -$17.39M derived: sum of 3 quarters · filed 2017-03-15 | -$22.12M 10-K · filed 2017-03-15 | |||||||||
| 2015-09-30 | -$5.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$10.58M derived: sum of 2 quarters · filed 2016-11-09 | -$15.31M 10-Q · filed 2016-11-09 | -$19.18M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-06-30 | -$5.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$10.18M 10-Q · filed 2016-08-04 | -$14.04M derived: sum of 3 quarters · filed 2017-03-15 | -$17.45M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-03-31 | -$4.73M 10-Q · filed 2016-05-10 | -$8.60M derived: sum of 2 quarters · filed 2017-03-15 | -$12.01M derived: sum of 3 quarters · filed 2017-03-15 | -$14.66M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2014-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$7.28M derived: sum of 2 quarters · filed 2017-03-15 | -$9.93M derived: sum of 3 quarters · filed 2017-03-15 | -$12.73M 10-K · filed 2017-03-15 | |||||||||
| 2014-09-30 | -$3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$6.06M derived: sum of 2 quarters · filed 2015-11-09 | -$8.86M 10-Q · filed 2015-11-09 | -$10.72M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$5.45M 10-Q · filed 2015-08-10 | -$7.31M derived: sum of 3 quarters · filed 2016-03-10 | -$9.40M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-03-31 | -$2.80M 10-Q · filed 2015-05-05 | -$4.65M derived: sum of 2 quarters · filed 2016-03-10 | -$6.75M derived: sum of 3 quarters · filed 2016-03-10 | -$8.49M derived: sum of 4 quarters · filed 2016-03-10 | -$35.13M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$3.95M derived: sum of 2 quarters · filed 2016-03-10 | -$5.69M derived: sum of 3 quarters · filed 2016-03-10 | -$7.32M 10-K · filed 2016-03-10 | -$32.33M 10-K · filed 2014-03-17 | ||||||||
| 2013-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$3.83M derived: sum of 2 quarters · filed 2014-11-06 | -$5.46M 10-Q · filed 2014-11-06 | -$6.78M derived: sum of 4 quarters · filed 2015-03-12 | -$30.47M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$3.36M 10-Q · filed 2014-08-07 | -$4.68M derived: sum of 3 quarters · filed 2015-03-12 | -$6.10M derived: sum of 4 quarters · filed 2015-03-12 | -$28.38M 10-Q · filed 2013-08-14 | ||||||||
| 2013-03-31 | -$1.63M 10-Q · filed 2014-05-12 | -$2.94M derived: sum of 2 quarters · filed 2015-03-12 | -$4.36M derived: sum of 3 quarters · filed 2015-03-12 | -$5.66M derived: sum of 4 quarters · filed 2015-03-12 | -$26.64M 10-Q · filed 2013-05-14 | ||||||||
| 2012-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$2.73M derived: sum of 2 quarters · filed 2015-03-12 | -$4.03M derived: sum of 3 quarters · filed 2015-03-12 | -$4.93M 10-K · filed 2015-03-12 | -$25.01M 10-K · filed 2013-04-01 | ||||||||
| 2012-09-30 | -$1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$2.71M derived: sum of 2 quarters · filed 2013-11-14 | -$3.62M 10-Q · filed 2013-11-14 | -$4.14M derived: sum of 4 quarters · filed 2014-03-17 | -$23.70M 10-Q · filed 2012-11-14 | ||||||||
| 2012-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.20M 10-Q · filed 2013-08-14 | -$2.72M derived: sum of 3 quarters · filed 2014-03-17 | -$3.12M derived: sum of 4 quarters · filed 2014-03-17 | -$22.28M 10-Q · filed 2012-08-14 | ||||||||
| 2012-03-31 | -$905.09K 10-Q · filed 2013-05-14 | -$1.43M derived: sum of 2 quarters · filed 2014-03-17 | -$1.82M derived: sum of 3 quarters · filed 2014-03-17 | -$2.27M derived: sum of 4 quarters · filed 2014-03-17 | -$20.98M 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | -$520.59K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$913.41K derived: sum of 2 quarters · filed 2014-03-17 | -$1.36M derived: sum of 3 quarters · filed 2014-03-17 | -$1.93M 10-K · filed 2014-03-17 | |||||||||
| 2011-09-30 | -$392.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$841.05K derived: sum of 2 quarters · filed 2012-11-14 | -$1.41M 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | -$448.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$1.02M 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | -$568.65K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |